These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6118718)

  • 21. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 23. Tamoxifen therapy in premenopausal women with metastatic breast cancer.
    Planting AS; Alexieva-Figusch J; Blonk-vdWijst J; van Putten WL
    Cancer Treat Rep; 1985 Apr; 69(4):363-8. PubMed ID: 3995508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
    Chrapusta SJ; Giermek J; Pieńkowski T
    Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.
    A'Hern RP; Wilson AJ; Baum M
    Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424
    [No Abstract]   [Full Text] [Related]  

  • 26. Rational approaches to the hormonal treatment of breast cancer.
    Allegra JC
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):25-8. PubMed ID: 6669986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated oestrogen receptors in breast cancer and response to endocrine therapy.
    Fernandez MD; Burn JI; Sauven PD; Parmar G; White JO; Myatt L
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):41-6. PubMed ID: 6537914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
    Namer M; Lalanne C; Baulieu EE
    Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The estrogen receptor test: a prognostic tool in primary breast cancer.
    Logan LA; Cripps MC; Hirte WE; Rapp EF
    Can J Surg; 1982 Sep; 25(5):581-4. PubMed ID: 7116258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer.
    Wander HE; Blossey HC; Nagel GA
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1371-4. PubMed ID: 3830219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].
    Zhang J; Zhang JH; Liu Y; Hao XM; Fang ZX; Li SL
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3268-71. PubMed ID: 18396622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results with tamoxifen in advanced mammary carcinoma.
    Kolb R; Jakesz R; Reiner H
    Recent Results Cancer Res; 1980; 71():146-8. PubMed ID: 7367726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oestradiol receptor values in breast cancer and response of metastases to therapy.
    Bryan RM; Mercer RJ; Bennett RC; Rennie GC; Lie TH; Morgan FJ
    Aust N Z J Surg; 1984 Feb; 54(1):3-6. PubMed ID: 6586164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.
    Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP
    Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
    Anderson ED; Forrest AP; Levack PA; Chetty U; Hawkins RA
    Br J Cancer; 1989 Aug; 60(2):223-6. PubMed ID: 2527549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.